Viewing Study NCT00329134



Ignite Creation Date: 2024-05-05 @ 4:49 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00329134
Status: COMPLETED
Last Update Posted: 2009-04-17
First Post: 2006-05-22

Brief Title: Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malaria
Sponsor: University Ghent
Organization: University Ghent

Study Overview

Official Title: Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malaria
Status: COMPLETED
Status Verified Date: 2009-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: No pediatric formulations of quinine exist Therefore quinine tablets are broken into 2 or 4 parts according to the body weight Based on the body weight 12 or 14 a tablet is administered to the child

At this moment quinine sulphate pellets are developed These pellets enable an adequate dosing according to the body weight

56 children with malaria will be dosed every 8 hours during 7 days with 10-15mgkg body weight
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None